首页> 美国卫生研究院文献>Pharmaceuticals >Tree-Based QSAR Model for Drug Repurposing in the Discovery of New Antibacterial Compounds against
【2h】

Tree-Based QSAR Model for Drug Repurposing in the Discovery of New Antibacterial Compounds against

机译:基于树的QSAR模型用于发现新抗菌化合物的药物重新抑制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Drug repurposing appears as an increasing popular tool in the search of new treatment options against bacteria. In this paper, a tree-based classification method using Linear Discriminant Analysis (LDA) and discrete indexes was used to create a QSAR (Quantitative Structure-Activity Relationship) model to predict antibacterial activity against Escherichia coli. The model consists on a hierarchical decision tree in which a discrete index is used to divide compounds into groups according to their values for said index in order to construct probability spaces. The second step consists in the calculation of a discriminant function which determines the prediction of the model. The model was used to screen the DrugBank database, identifying 134 drugs as possible antibacterial candidates. Out of these 134 drugs, 8 were antibacterial drugs, 67 were drugs approved for different pathologies and 55 were drugs in experimental stages. This methodology has proven to be a viable alternative to the traditional methods used to obtain prediction models based on LDA and its application provides interesting new drug candidates to be studied as repurposed antibacterial treatments. Furthermore, the topological indexes Nclass and Numhba have proven to have the ability to group active compounds effectively, which suggests a close relationship between them and the antibacterial activity of compounds against E. coli.
机译:药物重新淘汰在寻找对细菌的新治疗方案中寻找越来越多的流行工具。在本文中,使用使用线性判别分析(LDA)和离散指标的基于树的分类方法来产生QSAR(定量结构 - 活性关系)模型,以预测对大肠杆菌的抗菌活性。该模型包括在分层决策树上,其中使用离散索引用于根据所述索引的值将化合物分成组,以便构建概率空间。第二步骤包括计算确定模型预测的判别函数。该模型用于筛选药物库数据库,将134种药物鉴定为可能的抗菌候选者。在这134种药物中,8种药物是抗菌药物,67名是针对不同病理学批准的药物,55例是实验阶段的药物。该方法已被证明是用于获得基于LDA的预测模型的传统方法的可行替代方法,其应用为其提供了有趣的新药物候选者作为重新培育的抗菌治疗。此外,拓扑指数纳卡斯和NUMHBA已经证明能够有效地对活性化合物进行组化合物,这表明它们之间的密切关系和对大肠杆菌的化合物的抗菌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号